Close-up of the US and EU flags overlapping, showing white stars on the American flag and gold stars on the European Union flag, symbolising transatlantic pharmaceutical policy.

Europe’s pharmaceutical policy choices – And what the United States stands to learn

A recent policy discussion on Capitol Hill hosted by We Work For Health examined the lessons the United States might draw from Europe’s experience with pharmaceutical pricing and innovation. As a participant, my key takeaways focused on understanding the trade-offs underpinning EU and UK drug pricing policy and the broader impact on innovation for both sides of the Atlantic.